(Q33681753)

English

Determination of an optimal dosing regimen for fexinidazole, a novel oral drug for the treatment of human African trypanosomiasis: first-in-human studies

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 July 2017

Determination of an optimal dosing regimen for fexinidazole, a novel oral drug for the treatment of human African trypanosomiasis: first-in-human studies (English)

1 reference

Europe PubMed Central

28 July 2017

0 references

trypanosomiasis

0 references

African trypanosomiasis

0 references

Séverine Blesson

object named as

Séverine Blesson

2

0 references

author name string

Antoine Tarral

1

1 reference

Europe PubMed Central

28 July 2017

Olaf Valverde Mordt

3

1 reference

Europe PubMed Central

28 July 2017

Els Torreele

4

1 reference

Europe PubMed Central

28 July 2017

Daniela Sassella

5

1 reference

Europe PubMed Central

28 July 2017

Michael A Bray

6

1 reference

Europe PubMed Central

28 July 2017

Lionel Hovsepian

7

1 reference

Europe PubMed Central

28 July 2017

Eric Evène

8

1 reference

Europe PubMed Central

28 July 2017

Virginie Gualano

9

1 reference

Europe PubMed Central

28 July 2017

Mathieu Felices

10

1 reference

Europe PubMed Central

28 July 2017

Nathalie Strub-Wourgaft

11

1 reference

Europe PubMed Central

28 July 2017

publication date

1 June 2014

1 reference

Europe PubMed Central

28 July 2017

Clinical Pharmacokinetics

1 reference

Europe PubMed Central

28 July 2017

53

1 reference

Europe PubMed Central

28 July 2017

6

1 reference

Europe PubMed Central

28 July 2017

565-580

1 reference

Europe PubMed Central

28 July 2017

copyright license

Creative Commons Attribution-NonCommercial 2.5 Generic

18 February 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

https://scigraph.springernature.com/pub.10.1007/s40262-014-0136-3

0 references

Control and surveillance of human African trypanosomiasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037587

21 June 2018

Human African Trypanosomiasis in the Democratic Republic of the Congo: A Looming Emergency?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037587

21 June 2018

In-hospital safety in field conditions of nifurtimox eflornithine combination therapy (NECT) for T. b. gambiense sleeping sickness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037587

21 June 2018

Fexinidazole: a potential new drug candidate for Chagas disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037587

21 June 2018

The anti-trypanosome drug fexinidazole shows potential for treating visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037587

21 June 2018

Antitrypanosomal activity of fexinidazole, a new oral nitroimidazole drug candidate for treatment of sleeping sickness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037587

21 June 2018

Fexinidazole--a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037587

21 June 2018

Cross-resistance to nitro drugs and implications for treatment of human African trypanosomiasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037587

21 June 2018

Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037587

21 June 2018

A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037587

21 June 2018

Human African trypanosomiasis: pharmacological re-engagement with a neglected disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037587

21 June 2018

Effects of food and formulation on the relative bioavailability of bismuth biskalcitrate, metronidazole, and tetracycline given for Helicobacter pylori eradication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037587

21 June 2018

Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037587

21 June 2018

Transaminase elevation on placebo during phase I trials: prevalence and significance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037587

21 June 2018

A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037587

21 June 2018

The effects of gastric pH and food on the pharmacokinetics of a new oral cephalosporin, cefpodoxime proxetil.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037587

21 June 2018

Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037587

21 June 2018

Human African trypanosomiasis

2 references

https://api.crossref.org/works/10.1007%2FS40262-014-0136-3

21 January 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037587

10 December 2018

Genotoxicity profile of fexinidazole--a drug candidate in clinical development for human African trypanomiasis (sleeping sickness).

1 reference

https://api.crossref.org/works/10.1007%2FS40262-014-0136-3

21 January 2018

Chemotherapy of human african trypanosomiasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037587

30 October 2018

Near-thorough QT study as part of a first-in-man study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24535888

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S40262-014-0136-3

1 reference

Europe PubMed Central

28 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33681753&oldid=1862571866"